Introduction: Nerve growth factor (NGF), apart from its role as a growth factor, appears to be involved in neuroimmune interactions and in tissue in¯ammation. Low-anity nerve growth factor receptor (p 75 NGFR), if demonstrated in the urothelium, could provide the means for (1) NGF-mediated modulation of the urothelial response to in¯ammation; (2) NGF-mediated autocrine/paracrine regulation of urothelial proliferation; and (3) p 75 NGFRmediated induction of apoptosis. Objectives: To investigate the presence of p 75 NGFR in the vesical urothelium of patients with neuropathic bladder by immunohistochemical methods. Setting: A hospital-based study of consecutive, unselected, adult patients of either sex with neuropathic bladder, undergoing procedure on the urinary tract in a Regional Spinal Injuries Centre located in the north-west of England. Intervention: Cold cup biopsies were taken from the trigone of the neuropathic urinary bladder of 26 patients with neuropathic bladder. Immunohistochemical studies were performed using antiNGF-receptor human monoclonal antibody which reacts with the low anity receptor (p 75 NGFR). In many cases, the positively-stained nerve ®bres were coursing very close to the basal layer of the urothelium almost entering the urothelium; however, no NGFR-positive intra-epithelial terminals could be seen. The positively-stained single nerve ®bres and positively-stained thicker nerve bundles were seen in abundance in the submucosa but they were present in a sparse manner in the muscularis layer. Conclusion: The presence of p 75 NGFR was demonstrated in the urothelium of neuropathic bladder of all the 26 patients with neuropathic bladder. This observation may have potential therapeutic implications.
Introduction
Nerve growth factor Nerve growth factor (NGF), initially considered to be important for maintaining survival and providing guidance for target projection of peripheral sensory and sympathetic neurons, is now known to display a greatly extended spectrum of biological functions. NGF appears to be involved in neuroimmune interactions and tissue in¯ammation, with NGF acting as a general`alert' molecule capable of recruiting and priming both local tissue and systemic defense processes following stressful events. NGF can thus be viewed as a multifactorial mediator modulating neuroimmune-endocrine functions of vital importance to the regulation of homeostatic interactions, with potential involvement in pathological processes deriving from dysregulation of either local or systemic homeostatic balances. 1 p75 Low-anity nerve growth factor receptor (p75 NGFR) The neurotrophin family is distinguished by a unique signal transduction system represented by two dierent Table 1 The clinical details of the patients with paraplegia/tetraplegia in whom biopsy had been taken from the trigone of the neuropathic bladder, and ®ndings of the immunohistochemical studies for p 75 Neurotrophins initiate biological actions by binding to cell surface receptors, followed by receptor-mediated internalization, increased cellular tyrosine phosphorylation, retrograde transport, and the activation of numerous eectors molecules, such as protein kinases, phospholipases, and transcriptional activators. 2 The neurotrophin receptor p75 has emerged as a receptor with a multiplicity of roles. As a neurotrophin receptor subunit, p75 profoundly aects tyrosine kinase function on many levels, providing an additional mechanism for cells to modulate neurotrophin actions. In addition, p75 also can function alone to regulate gene expression, cell migration, and apoptotic events. The dierent aspects of p75 activity may ultimately depend upon the cell context and environment, the ratio of tyrosine kinase to p75 expression, and the presence of neurotrophins. 3 Bladder distension and NGF production by smooth muscle Neuropathic bladder dysfunction may be associated with functional, (commonly) chronic, obstruction at the bladder neck and/or at the external sphincter. The urinary bladder undergoes anatomical, biochemical, pharmacological, and physiological changes in response to the functional demands of chronic obstruction. 4 Acute bladder outlet obstruction, (as occurs when an indwelling urinary catheter is blocked), elicits a relative denervation of the bladder with axonal degeneration with subsequent reinnervation of smooth muscle as shown by ultrastructural studies. 5 Mechanical stretch of cultured smooth muscle from the urinary tract elicits rapid accumulation of nerve growth factor messenger RNA followed by secretion of nerve growth factor protein. 6 Low-anity NGFR immunoreactive ®bres in the human urinary bladder Wakabayashi et al 7 studied low-anity nerve growth factor receptor (LNGFR) immunoreactive ®bres in the specimens obtained during urological surgery from the anterior wall of the bladder body of nine neurologically normal patients. LNGFR immunoreactive nerve ®bres were observed in the lamina propria, submucosal layer and muscle layer, but not in the epithelium. The distribution of LNGFR-positive ®bres were more abundant in the lamina propria than in the muscle layer. Most of the LNGFR immunoreactive nerve ®bres in the lamina propria ran freely, but some were accompanied by blood vessels. Double immunostaining for low-anity nerve growth factor receptor and tyrosine hydroxylase (used as a marker of adrenergic nerves in the urinary bladder) demonstrated that some low-anity nerve growth factor-positive ®bre bundles contained tyrosine hydroxylase immunoreactivity and others did not; thus it is likely that LNGFR-positive ®bre bundles enclose various nerves that are not exclusive to adrenergic nerves. As the density of LNGFR-positive ®bres was more abundant in the mucosal layer than in the muscle layer, Wakabayashi et al 7 suggested that epithelial cells in the human urinary bladder could produce nerve growth factor in normal conditions, and the LNGFR-positive ®bres in the mucosa might be related to the trophic action on the innervating neurons. However, these authors did not refer to the presence of LNGFR immunoreactivity in the non-neural tissues such as the vesical epithelium, macrophages, or the lymphoid tissue in the bladder biopsies they studied.
Is p75 neurotrophin receptor present in vesical urothelium?
In view of the presence of NGFR in epithelial structures such as the oral mucosa 8 and in prostatic epithelium, 9 it is likely that p 75 NGFR may be located in the vesical urothelium. The presence of p 75 NGFR in the urothelium could subserve the following physiological roles: (1) NGF-mediated autocrine/ paracrine regulation of urothelial proliferation; (2) NGF-mediated modulation of urothelial response to in¯ammation; (3) The constitutive activity p 75 NGFR in the induction of apoptosis (a process known as programmed cell death, which is an active form of cellular suicide, that typically requires ATP, involves new RNA and protein synthesis, and that culminates in the activation of endogenous endonucleases that degrade the DNA of the cell, thereby destroying the genetic template required for cellular homeostasis).
We undertook a study to investigate the presence of p 75 NGFR in the vesical urothelium of patients with neuropathic bladder. If p 75 NGFR is shown to be present in the urothelium, this ®nding may open the avenue for innovative treatment strategies targeted at the p 75 NGFR, as therapeutic applications of neurotrophic growth factors are no longer a distant goal but rather a pratical reality. 10 
Patients and methods
Cold cup biopsies of the trigone of the urinary bladder were taken with Storz rigid cystoscope 22 Fr. from adult patients of either sex with neuropathic bladder dysfunction undergoing a therapeutic procedure such as electrohydraulic lithotrispy of vesical stone(s), JJ stenting of the ureter prior to extracorporeal shock wave lithotripsy of renal stone(s), transurethral resection of bladder neck or division of external urethral sphincter. All the participants gave written informed consent for taking bladder biopsy. Of the two biopsy specimens taken from the trigone of the urinary bladder, one biopsy specimen was preserved in buered formaldehyde for routine histopathological examination. The other biopsy specimen was covered with OTC compound to prevent dehydration, then it was snap frozen in liquid nitrogen. Thereafter, the biopsy specimen was stored at 7808C until the immunohistochemical studies were performed for p 75 
Results
The clinical details of the 26 patients with a neuropathic bladder, and the results of the immunohistochemical ®ndings of the individual patients are listed in Table 1 . Seventeen patients had sustained a spinal cord injury; four had spina bi®da with paraplegia; three patients had tetraplegia of nontraumatic origin; one patient had paraplegia due to viral myelitis; and one patient had multiple sclerosis. Immunohistochemical staining of bladder biopsies for p 75 Nerve Growth Factor Receptor in patients with neuropathic bladder revealed the following features: (1) Both neural and epithelial structures showed positive immunostaining; (2) The basal layer of the transitional epithelium showed strongly positive immunostaining for p 75 NGFR in all the cases ( Figure 1) ; (3) The luminal layer of transitional epithelium showed varying degree of positive immunostaining (low to medium to strong intensity) for p 75 NGFR in 12 patients ( Figure 2) ; in one of them (BL), the surface layer of the transitional epithelium showed positive staining and gave an impression as though it was secreting the material into the lumen; (4) In contrast to the above, in those bladder biopsy specimens in which the transitional epithelium had undergone squamous metaplasia, the basal layer of the squamous metaplastic epithelium showed varying degree of positivity (low to medium to strong intensity) for p 75 NGFR immunostaining, or no positive immunostaining at all ( Figure 3) ; (5) The pattern of immunostaining in the epithelium was peripheral', suggesting that the p 75 NGFR immunoreactivity was located at the plasma membrane; (6) The nerve ®bres coursing below the transitional epithelium showed positive immunostaining for p 75 NGFR. In many cases, the nerve ®bres were running in a random manner in the submucosa (Figure 4) . In some biopsy specimens, the positively-stained nerve ®bres were coursing very close to the basal layer of the urothelium almost entering the urothelium ( Figure  5) ; however, no NGFR-positive intra-epithelial terminals could be seen; (7) The positively-stained single nerve ®bres and positively-stained thicker nerve bundles were seen in abundance in the submucosa ( Figure 6) ; however, the positively-stained nerve ®bres were present in a sparse manner in the muscularis layer; (8) The positive immunostaining for p 75 NGFR appeared continuous along the basal layer of the urothelium, and in squamous metaplastic epithelium when present, without variations in intensity, independently of the presence and abundance of super®cial nerve ®bres; (9) In many cases, the macrophages in the submucosa showed positive staining for p 75 NGFR; (10) Lymphoid tissue (including lymphoid follicles) was seen in some of the bladder biopsies; but there was no unequivocal positive immunostaining of the cells within the lymphoid tisuse.
Discussion
Positive immunostaining for p 75 NGFR was demonstrated in neural as well as epithelial structures in the biopsies taken from the trigone of patients with neuropathic urinary bladder dysfunction. Wakabayashi et al 7 studied bladder tissue taken from the anterior walls of bladder body of nine neurologically normal subjects, and they did not observe low-anity nerve growth factor receptor (LNGFR) immunoreactive ®bres in the vesical epithelium. These authors did not allude to LNGFR immunoreactive staining by nonneural tissue such as the epithelium, the macrophages and the lymphoid tissue in the bladder biopsies studied by them. In the present study also, no NGFR-positive intra-epithelial terminals could be seen. In the neuropathic bladder, p 75 NGFR might play a role in: (1) cell proliferation and apoptosis; (2) regulating the in¯ammatory changes (cystitis) in the bladder mucosa; (3) development and maintenance of mucosal innervation; (4) modulation of the urinary bladder stretch response in which a physical stimulus of distension of the bladder is transduced into a cascade of biochemical responses culminating in the production of nerve growth factor by the smooth muscle cells.
The presence of p 75 NGFR in the luminal layer of the urothelium in 12 of the 26 biopsy specimens taken from patients with neuropathic bladder, and the presence of p 75 NGFR in the basal layer of the urothelium in all the biopsy specimens, may oer an opportunity for designing possible innovative treatment strategies targeted at the p 75 receptor. A molecular biological approach aimed at modulating the function of neuropathic bladder may become possible, 13 and it might involve the administration of either the ligands for the p 75 NGFR which would activate the receptor, eg nerve growth factor, or the administration of substances that would block the action(s) of p 75 NGFR, as p 75 NGFR has multifarious functions, apart from its classical role as a growth factor receptors.
